EDGAR Filing Documents for 0001193125-09-158883

Form 8-K - Current report:

SEC Accession No. 0001193125-09-158883

Filing Date

2009-07-30

Accepted

2009-07-30 08:01:48

Documents

Period of Report

2009-07-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	25826
2	CERTIFICATE OF DESIGNATION	dex38.htm	EX-3.8	103238
3	SECURITIES PURCHASE AGREEMENT	dex10114.htm	EX-10.114	361593
4	PRESS RELEASE	dex991.htm	EX-99.1	10133
5	GRAPHIC	g84981ex99_1.jpg	GRAPHIC	6597
	Complete submission text file	0001193125-09-158883.txt		511842

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)